Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

917473

	registered interest
	date	05/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Yorkshire and the Humber
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many GP trainees began training in (a) York and (b) Yorkshire and the Humber in the most recent year for which statistics are available.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	150089
	answer	answer is ministerial correction date of answer 12/06/2018 answer text <p>We do not hold data on the number of general practitioner (GP) trainees who started training in York and Yorkshire and the Humber. The number of GP registrars working in general practice in the Vale of York Clinical Commissioning Group and NHS England North (Yorkshire and the Humber) in September 2017 is presented in the following table. This may not represent all trainee GPs in these regions as they do not spend the entirety of their training as a GP registrar working in general practice. The remaining time is spent training in hospitals.</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>GP Registrars (Full Time Equivalent (FTE))</p></td><td><p>GP Registrars (Headcount)</p></td></tr><tr><td><p>NHS Vale of York CCG</p></td><td><p>12</p></td><td><p>13</p></td></tr><tr><td><p>NHS England North (Yorkshire and Humber)</p></td><td><p>244</p></td><td><p>277</p></td></tr></tbody></table><p> </p><p>Notes:</p><p><strong> </strong></p><p>1. Figures contain estimates for the 5.4% of practices that did not provide fully valid GP data.</p><p> </p><p>2. FTE refers to the proportion of full time contracted hours that the post holder is contracted to work. 1 would indicate they work a full set of hours, 0.5 that they worked half time.</p><p> </p><p>3. Figures shown do not include GPs working in Prisons, Army Bases, Educational Establishments, Specialist Care Centres including Drug Rehabilitation Centres and Walk-In Centres.</p><p> </p><p>Data as at 30 September</p><p> </p><p>Source: NHS Digital</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/06/2018 15:17:21 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

917475

	registered interest
	date	05/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: York
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many GP trainers were registered in York in the most recent year for which information is available; and how many were so registered five years ago.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	150090
	answer	answer is ministerial correction date of answer 12/06/2018 answer text <p>The York general practitioner (GP) specialty training scheme is well established, respected, evaluated and popular with those choosing to train to become GPs. It attracted higher than regional-average fill rates in the last round of GP recruitment. The scheme has three experienced training programme directors (TPD) that are responsible for the support and delivery of teaching and training for trainees at weekly group sessions, as well as the planning and delivery of training rotations in the area, and support for local GP trainers. The ratio of TPD sessions to trainees is higher than the average for Yorkshire and the Humber.</p><p> </p><p>The training scheme usually operates from postgraduate education centre at York District Hospital. There have been recent renovations to this facility and there is a current period of adaptation and re-organisation, which Health Education England is supporting locally, to make the facilities ideal for all parties.</p><p> </p><p>GP trainers are responsible for the day-to-day supervision of trainee GPs who are on placements in practices. In the year August 2016 to July 2017 there were 34 headcount GP trainers linked to the York GP Speciality Training Programme. Data held prior to this period is not comparable.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 150091 question first answered 12/06/2018 15:25:29 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

867178

	registered interest
	date	19/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will bring forward the scheduled review of the Cystic Fibrosis drug Orkambi.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	133296
	answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>The Government has made no such assessment itself. The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources. NICE published guidance on the use of Orkambi for the treatment of cystic fibrosis in July 2016 and was not able to recommend it for routine use on the NHS.</p><p> </p><p>NICE has advised that it has not been notified of any new data published in February 2018 related to the use of Orkambi. NICE periodically reviews its technology appraisal guidance to determine whether any new evidence, including new trial data, has emerged that may affect its original recommendations. NICE is next scheduled to review its guidance on the use of Orkambi in July 2019, at which point it will conduct a search for new evidence. NICE’s guidance may be reviewed before the expected review date if significant new evidence emerges that is likely to change the recommendations. The company or any other stakeholder can alert NICE to new evidence in line with its established processes to request an early review.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 133299 question first answered 27/03/2018 11:54:59 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

819992

	registered interest
	date	10/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will introduce a national minor ailments scheme as part of the Pharmacy Integration Fund, and if he will make a statement.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	122064
	answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Minor ailment services are commissioned locally by the National Health Service according to need. The purpose of the Pharmacy Integration Fund (PhIF) is to try out and evaluate new ways of integrating pharmacists and community pharmacy into the wider health care system. National commissioning of NHS pharmaceutical services is arranged through the Community Pharmacy Contractual Framework. In December 2017, under the PhIF, NHS England commenced a pilot urgent minor illness care pathway of direct referral from NHS 111 to community pharmacy. The outcome of this pilot will inform future commissioning decisions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 14:11:29 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

867181

	registered interest
	date	19/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made for the implications for its policy of new data published by Vertex Pharmaceuticals in February 2018 on the Cystic Fibrosis drug Orkambi.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	133299
	answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>The Government has made no such assessment itself. The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent a clinically and cost effective use of NHS resources. NICE published guidance on the use of Orkambi for the treatment of cystic fibrosis in July 2016 and was not able to recommend it for routine use on the NHS.</p><p> </p><p>NICE has advised that it has not been notified of any new data published in February 2018 related to the use of Orkambi. NICE periodically reviews its technology appraisal guidance to determine whether any new evidence, including new trial data, has emerged that may affect its original recommendations. NICE is next scheduled to review its guidance on the use of Orkambi in July 2019, at which point it will conduct a search for new evidence. NICE’s guidance may be reviewed before the expected review date if significant new evidence emerges that is likely to change the recommendations. The company or any other stakeholder can alert NICE to new evidence in line with its established processes to request an early review.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 133296 question first answered 27/03/2018 11:54:59 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

906365

	registered interest
	date	17/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Acupuncture
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the availability of acupuncture on the NHS in each Clinical Commissioning Groups in England.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	145325
	answer	answer is ministerial correction date of answer 23/05/2018 answer text <p>No such assessment has been made. It is the responsibility of clinical commissioning groups to make decisions on the commissioning and funding of any health care treatments for National Health Service patients, such as acupuncture, taking account of issues to do with safety, clinical and cost-effectiveness and the availability of suitably qualified or regulated practitioners.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/05/2018 15:37:33 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

1063958

	registered interest
	date	19/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Overseas Companies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of GP consortia that are run for profit by overseas-based medical insurance firms.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	223130
	answer	answer is ministerial correction date of answer 26/02/2019 answer text <p>This information is not collected or held centrally.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 223127 question first answered 26/02/2019 15:35:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

867419

	registered interest
	date	20/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the potential savings to the public purse from the health service encouraging the uptake of e-cigarettes among smokers.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	133394
	answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>The potential financial impacts of e-cigarettes on the public purse are not yet fully understood. The evidence base is still evolving on these products, largely because vaping is still relatively new and the health effects may be very long term. Significant savings to the public purse are likely to arise only if smokers switch completely from smoked tobacco. The Government’s Tobacco Control Plan, published in July 2017, estimates that the National Health Service currently spends £2.5 billion on treating smoking-related diseases and Public Health England assess e-cigarettes to be at least 95% less harmful than smoked tobacco. Reduced harm may not translate exactly into proportional costs savings, but superficially this implies that vaping, as an alternative to smoking, may contribute to significant savings.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/03/2018 14:37:44 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

1008480

	registered interest
	date	16/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the potential savings to the NHS of making flash glucose monitoring technology available to all patients with diabetes across NHS clinical commissioning groups.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	192109
	answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>Following an announcement by NHS England on 14 November 2018, flash glucose monitoring systems will be made available on prescription for all patients with type 1 diabetes who meet National Health Service criteria from April 2019.</p><p> </p><p>No estimate has been made of the potential savings related to making flash glucose monitoring technology available to all patients with diabetes.</p><p> </p><p>A search of the Department’s Ministerial correspondence database has identified 272 items of correspondence from members of the public received in 2018 about flash glucose monitoring. This figure represents correspondence received by the Department’s Ministerial correspondence unit only. The Department has not been able to identify any correspondence specifically from charities.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192108 192110 question first answered 26/11/2018 17:43:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy

823446

	registered interest
	date	16/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to increase the supply of flu vaccines to areas in the event that there are shortfalls of such vaccines during Winter 2017-18.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	122924
	answer	answer is ministerial correction date of answer 24/01/2018 answer text <p>Flu vaccines for people aged 18 years and older are procured directly from manufacturers and suppliers by providers. The procurement and distribution of flu vaccines for the children’s aspect of the national flu programme is managed by Public Health England.</p><p> </p><p>Flu vaccine remains available to order from manufacturers and suppliers across England for both the adult and the children’s aspects of the national flu immunisation programme.</p><p> </p><p>Officials are continuously monitoring the flu vaccine supply landscape to enable timely and appropriate action to be taken in the event that demand begins to outweigh the amount of flu vaccine that is currently available to patients.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 122923 question first answered 24/01/2018 11:59:58 answering member 4067 label Biography information for Steve Brine
	tabling member	4079 label Biography information for Julian Sturdy